Use of PEI-coated magnetic iron oxide nanoparticles as gene vectors

Abstract

To evaluate the feasibility of using polyethyleneimine (PEI) coated magnetic iron oxide nanoparticles (polyMAG-1000) as gene vectors. The surface characteristics of the nanoparticles were observed with scanning electron microscopy. The ability of the nanoparticles to combine with and protect DNA was investigated at different PH values after polyMAG-1000 and DNA were combined in different ratios. The nanoparticles were tested as gene vectors with in vitro transfection models. Under the scanning electron microscope the nanoparticles were about 100 nm in diameter. The nanoparticles could bind and condense DNA under acid, neutral and alkaline conditions, and they could transfer genes into cells and express green fluorescent proteins (GFP). The transfection efficiency was highest (51%) when the ratio of nanoparticles to DNA was 1∶1 (v∶w). In that ratio, the difference in transfection efficiency was marked depending on whether a magnetic field was present or not: about 10% when it was absent but 51% when it was present. The magnetic iron oxide nanoparticles coated with PEI may potentially be used as gene vectors.

Keywords

magnetic iron oxide nanoparticles / polyethyleneimine / non-viral vectors / gene therapy

References

[1] KanedaY. New vector innovation for drug delivery: development of fusigenic non-viral particles. Curr Drug Targets, 2003, 4(8): 599-599

[2] OgrisM, WalkerG, BlessingT, et al. . Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release, 2003, 91(1–2): 173-173

[3] MeyerF, FinerM. Gene therapy: progress and challenges. Cell Mol Biol, 2001, 47(8): 1277-1277

[4] ThomasM, KlibanovA M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol, 2003, 62(1): 27-27

[5] VijayanathanV, ThomasT, ThomasT J. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry, 2002, 41(48): 14085-14085

[6] MerdanT, KopecekJ, KisselT. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev, 2002, 54(5): 715-715

[7] BrokxR, GariepyJ. Peptide-and polymer-based gene delivery vehicles. Methods Mol Med, 2004, 90: 139-139

[8] SchererF, AntonM, SchillimgerU, et al. . Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther, 2002, 9(2): 102-102

[9] MooreA, MarecosE, BogdanovA, et al. . Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology, 2000, 214(2): 568-568

[10] XiangJ J, TangJ Q, ZhuS G, et al. . IONP-PLL: a novel non-viral vector for efficient gene delivery. J Gene Med, 2003, 5(9): 803-803

[11] PlankC, SchererF, SohnH Y, et al. . Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J Liposome Res, 2003, 13(1): 29-29

[12] SomiaN. Gene delivery to cells in culture using retroviruses. Methods Mol Biol, 2004, 246(1): 491-491